DexCom
DXCM
202 hedge funds and large institutions have $2.48B invested in DexCom in 2013 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 59 increasing their positions, 84 reducing their positions, and 9 closing their positions.
322% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 9
133% more funds holding in top 10
Funds holding in top 10: 3 → 7 (+4)
23% more capital invested
Capital invested by funds: $2.02B → $2.48B (+$458M)
15% more funds holding
Funds holding: 175 → 202 (+27)
30% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 84
40% less call options, than puts
Call options by funds: $2.44M | Put options by funds: $4.07M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$40.1M |
| 2 |
Renaissance Technologies
New York
|
+$11.1M |
| 3 |
CM
Castleark Management
Chicago,
Illinois
|
+$10.2M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$9.35M |
| 5 |
JC
Jetstream Capital
Brentwood,
Tennessee
|
+$7.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
-$66.2M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$40.3M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$25.7M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$18.9M |
| 5 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$8.45M |
DXCM Hedge Fund Activity: Q4 2013 in Review
202 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q4 2013, worth a combined $2.48B — up 23% from $2.02B a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new DXCM positions and 9 closed out — a net gain of 29 holders — while 59 added to existing stakes and 84 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $40.1M. The largest seller was OppenheimerFunds, cutting an estimated $66.2M.
- 202 institutional investors held DexCom (DXCM) as of Q4 2013, up from 175 in Q3 2013.
- Funds reported $2.48B of DexCom stock for Q4 2013, up 23% quarter-over-quarter.
- 38 funds opened new DexCom positions in Q4 2013 and 9 closed out, a net change of +29 holders.
- The largest DexCom buyer in Q4 2013 was Fidelity Investments, an estimated $40.1M added.
- The largest DexCom seller in Q4 2013 was OppenheimerFunds, an estimated $66.2M sold.
Based on aggregated 13F filings for Q4 2013.